Page 22 - Segments Profiled News Today

The global Head and Neck Cancer (HNC) Therapeutics market is anticipated to surpass a remarkable worth of US$ 1.58 Billion in 2023, with a compound annual growth rate (CAGR) of 12.6% from 2023 to 2033. Developments in the detection and treatment of head and neck cancer (HNC) are expected to propel market expansion a...

A recently published study by FMI expects the global common warts market to augment at a 3.6% CAGR from 2023 to 2033. By the end of the said assessment period, a valuation of US$ 1,100 Million is expected for the market. The increase in pharmaceutical R&D activity for efficient and focused treatment of common warts...

[Report of 250 Pages] In 2032, the market for neuro monitoring systems is expected to be worth US$9.4 billion. The market for neuro monitoring systems is expected to grow in the coming years due to the rising number of complicated and critical surgeries performed around the world. The demand for neuro monitoring sys...

The global malignant pleural effusion market is expected to garner a market value of US$ 4.5 Billion in 2023 and is expected to accumulate a market value of US$ 8.06 Billion by registering a CAGR of 6% in the forecast period 2023-2033. The increasing incidence of pleural effusion disease and rising awareness of adva...

NAATs Expected to Hold 49% Of Market Share for Chlamydia diagnostics Market. The Chlamydia Diagnostics Market refers to the market for tests and assays...

Governmental Initiatives toward the Development of Affordable Housing to be the Key Factor Expected to Assist the Consumption Growth of Ready-Mix Concrete....

The global cancer vaccine market is expected to grow significantly in the coming years, according to a new report published by Future Market Insights. The report predicts that the market will grow at a compound annual growth rate (CAGR) of 12% from 2023 to 2033, reaching a value of US$ 24.22 Billion by the end of th...

According to Future Market Insights, global filariasis treatment is expected to grow at a CAGR of 10.1% between 2023 and 2033, reaching US$ 28.68 billion in 2033. The increasing prevalence of filariasis and improved diagnostic capabilities are expected to drive growth in the filariasis treatment market. The availabi...

The global hyperpigmentation treatment market is predicted to exceed an impressive valuation with a compound annual growth rate (CAGR) of 7.4% projected from 2023 to 2033. Skin hyperpigmentation results from a slight decrease in melanin synthesis. Laser treatment, cosmeceuticals, and chemical peels can all be used t...

The global Eisenmenger complex management market is expected to surpass an impressive valuation of US$ 7.7 billion in 2023 and is projected to reach US$ 12.9 billion by 2033, growing at a CAGR of 5.3%. Generally, the treatment includes relieving the symptoms and associated co-morbidities. Medications such as calcium...